Position in TLRY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$115,469
New position
Shares Held
17,847
first reported quarter
Ownership
0.015%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 8%
Shared 36%
None 57%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Cerity Partners LLC holds $73,705,978 across 27 Drug Manufacturers - Specialty & Generic names. TLRY ranks #22 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
144,529 | $19,040,248 | |
| 2 | ZTS |
Zoetis Inc.
|
127,682 | $15,093,288 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
24,368 | $14,449,735 | |
| 4 | HLN |
Haleon plc
|
459,205 | $4,596,640 | |
| 5 | VTRS |
Viatris Inc
|
306,139 | $4,135,936 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
85,414 | $2,572,668 | |
| 7 | TAK |
Takeda Pharmaceutical Co Ltd
|
136,388 | $2,525,904 | |
| 8 | RDY |
Dr Reddys Laboratories Ltd
|
181,595 | $2,515,090 |
All Filings in TLRY
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $115,469 | 17,847 | Shares | Other | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||